NXL - Nexalin Technology, Inc. Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Nexalin (NXL)

Nexalin Technology, Inc. (NXL) holds patents for neurostimulation frequencies used to combat depression, ensuring long-term revenue. The price-to-sales multiple on the GURU.Markets system consolidated chart shows that the indicator level is 7.80. Business growth is based on FDA approvals, although vulnerability in protection necessitates expanded insurance coverage and recognition of the method by leading clinics.

NXL - Nexalin Technology, Inc. P/S Multiple over the range 04/28/2023 - 11/13/2026

Analytical breakdowns for Nexalin Technology, Inc. (NXL)

- stock price and consensus target price:
Share Price nexalin.com|NXL - Consensus Target
- market capitalization statistics:
Market Value Nexalin|NXL - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Price of a Share Nexalin Technology|NXL - Book Capitalization|Market-to-Book Ratio nexalin.com|NXL - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Nexalin Technology, Inc.|NXL - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital nexalin.com|NXL - Company Debts|Debt to Book Value Ratio Nexalin|NXL - Company Long-Term Debt|Short-Term Debt Nexalin Technology|Quick Liquidity nexalin.com
- earnings and market ratios statistics:
NXL - Company Net Income|Expected Net Profit Nexalin Technology, Inc.|NXL - P/E Multiple|Forward Price to Earnings Multiple nexalin.com|NXL - Price/Earnings to Growth Multiple|Company Value to EBITDA Nexalin|NXL - Operating profit before deduction of amortization|Earnings per share for the trailing year Nexalin Technology|NXL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months nexalin.com|NXL - Earnings per share growth in current year|Projected earnings per share growth rate for next year Nexalin Technology, Inc.
- issuer revenue and sales details:
NXL - Revenue and Sales Volume|Company Future Sales Volume nexalin.com|NXL - Market Cap to Revenue|Market Cap to Expected Sales Ratio Nexalin
Fundamental company analysis:Nexalin Technology Inc (NXL)
Original product of Nexalin Technology

For Nexalin Technology, Inc. (NXL), which develops non-invasive brain stimulation systems, the P/S ratio serves as a measure of market value relative to revenue. This metric is calculated by dividing the total market capitalization by annual sales volume. By analyzing the price-to-sales trend, an investor determines the extent of the premium paid for the innovative potential of the neurobiological product. The stability of this indicator confirms the adequacy of the business valuation amid the scaling of medical technologies.

Competitors of Nexalin Technology, Inc.

acadiahealthcare.com - Market Cap to Revenue Ratio|LifeStance Health - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BWAY